CLINICAL_TRIALS
trial_result
· 2015-01-14
Clinical Trial Update: Janssen Asperger's MRS (Magnetic Resonance Spectroscopy Risperidone Study [Phase 4]
Summary
Phase 4 study evaluating risperidone using magnetic resonance spectroscopy for individuals with Asperger syndrome has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Augusta University | Conditions: Asperger's Disorder | Phase 4 | Status: COMPLETED